Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register

BACKGROUND AND AIMS: The International Atherosclerosis Society (IAS) has proposed that patients with “severe” FH (SFH) would warrant early and more aggressive cholesterol-lowering treatment such as with PCSK9 inhibitors. SFH is diagnosed if LDL-cholesterol (LDLC) > 10 mmol/L, or LDLC >8.0 mmol...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphries, Steve E., Cooper, Jackie A., Capps, Nigel, Durrington, Paul N., Jones, Ben, McDowell, Ian F.W., Soran, Handrean, Neil, Andrew H.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403443/
https://www.ncbi.nlm.nih.gov/pubmed/30458964
http://dx.doi.org/10.1016/j.atherosclerosis.2018.11.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403443/
https://www.ncbi.nlm.nih.gov/pubmed/30458964
http://dx.doi.org/10.1016/j.atherosclerosis.2018.11.014

Ejemplares similares